THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 122 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,813 | +1265.5% | 325,985 | +1536.4% | 0.24% | +1047.6% |
| Q2 2023 | $206 | -82.0% | 19,921 | -81.1% | 0.02% | -81.4% |
| Q1 2023 | $1,142 | +76.8% | 105,263 | +82.8% | 0.11% | +41.2% |
| Q4 2022 | $646 | -99.9% | 57,577 | -49.8% | 0.08% | -48.7% |
| Q2 2022 | $1,039,000 | +119.7% | 114,646 | +131.8% | 0.16% | +147.6% |
| Q1 2022 | $473,000 | +129.6% | 49,456 | +254.1% | 0.06% | +85.3% |
| Q3 2020 | $206,000 | -1.4% | 13,965 | +30.0% | 0.03% | +21.4% |
| Q3 2019 | $209,000 | – | 10,745 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 11,213,879 | $254,331,000 | 30.84% |
| Cormorant Asset Management, LP | 1,300,000 | $29,484,000 | 2.18% |
| Baupost Group | 9,309,168 | $211,132,000 | 1.85% |
| SENZAR ASSET MANAGEMENT, LLC | 27,397 | $621,000 | 1.79% |
| ARMISTICE CAPITAL, LLC | 1,180,000 | $26,762,000 | 1.75% |
| Old West Investment Management, LLC | 111,101 | $2,519,000 | 1.27% |
| Chescapmanager LLC | 403,321 | $9,147,000 | 1.06% |
| Virtus ETF Advisers LLC | 30,055 | $682,000 | 0.60% |
| Rock Springs Capital Management LP | 652,600 | $14,801,000 | 0.57% |
| Foundation Asset Management, LP | 27,154 | $616,000 | 0.53% |